PL1686972T3 - Kompozycja możliwa do rozpylania dla podawania pochodnych witaminy D - Google Patents

Kompozycja możliwa do rozpylania dla podawania pochodnych witaminy D

Info

Publication number: PL1686972T3
Authority: PL; Poland
Prior art keywords: vitamin; administration; derivatives; sprayable composition; composition
Prior art date: 2003-11-21

Application number

PL04803732T

Other languages

English (en)

Inventor

Franck Pitre

Laurent Fredon

Claire Mallard

Original Assignee

Galderma Res & Dev

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-11-21

Filing date

2004-11-17

Publication date

2008-09-30

2003-11-21 Priority claimed from FR0313660A external-priority patent/FR2862540B1/fr

2004-11-17 Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev

2008-09-30 Publication of PL1686972T3 publication Critical patent/PL1686972T3/pl

Links

239000000203 mixture Substances 0.000 title abstract 2
150000003710 vitamin D derivatives Chemical class 0.000 title 1
GMRQFYUYWCNGIN-NKMMMXOESA-N calcitriol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-NKMMMXOESA-N 0.000 abstract 1
229960005084 calcitriol Drugs 0.000 abstract 1
235000020964 calcitriol Nutrition 0.000 abstract 1
239000011612 calcitriol Substances 0.000 abstract 1
239000002537 cosmetic Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
229920001296 polysiloxane Polymers 0.000 abstract 1
239000007921 spray Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
- A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Heart & Thoracic Surgery (AREA)
Epidemiology (AREA)
Cardiology (AREA)
Diabetes (AREA)
Immunology (AREA)
Pulmonology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Obesity (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Hematology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Emergency Medicine (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL04803732T 2003-11-21 2004-11-17 Kompozycja możliwa do rozpylania dla podawania pochodnych witaminy D PL1686972T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
FR0313660A FR2862540B1 (fr)	2003-11-21	2003-11-21	Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
US54124504P	2004-02-04	2004-02-04
EP04803732A EP1686972B1 (en)	2003-11-21	2004-11-17	Sprayable composition for the administration of vitamin d derivatives
PCT/EP2004/014085 WO2005053666A1 (en)	2003-11-21	2004-11-17	Sprayable composition for the administration of vitamin d derivatives

Publications (1)

Publication Number	Publication Date
PL1686972T3 true PL1686972T3 (pl)	2008-09-30

Family

ID=34655190

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL04803732T PL1686972T3 (pl)	2003-11-21	2004-11-17	Kompozycja możliwa do rozpylania dla podawania pochodnych witaminy D

Country Status (15)

Country	Link
EP (2)	EP1952808A3 (pl)
JP (1)	JP2007511578A (pl)
AT (1)	ATE388697T1 (pl)
AU (1)	AU2004294728A1 (pl)
BR (1)	BRPI0416311A (pl)
CA (1)	CA2543577A1 (pl)
CY (1)	CY1107942T1 (pl)
DE (1)	DE602004012440T2 (pl)
DK (1)	DK1686972T3 (pl)
ES (1)	ES2302060T3 (pl)
MX (1)	MXPA06005587A (pl)
PL (1)	PL1686972T3 (pl)
PT (1)	PT1686972E (pl)
RU (1)	RU2006121973A (pl)
WO (1)	WO2005053666A1 (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL164152A0 (en)	2002-03-26	2005-12-18	Teva Pharma	Drug microparticles
FR2867682B1 (fr) *	2004-03-22	2009-06-05	Galderma Res & Dev	Composition pharmaceutique anhydre associant un agent silicone et un principe actif solubilise.
BRPI0613230A2 (pt) *	2005-06-10	2011-01-04	Galderma Sa	método para a liberação controlada de uma droga, método de administração, método de tratamento de distúrbios da pele, composição de liberação controlada e uso de uma composição
FR2887150B1 (fr) *	2005-06-17	2007-08-03	Galderma Res & Dev	Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise
FR2893845B1 (fr) *	2005-11-30	2010-10-29	Galderma Sa	Composition sous forme de spray comprenant un corticoide et une phase huileuse
JP2009532489A (ja) *	2006-04-03	2009-09-10	テバファーマシューティカルインダストリーズリミティド	薬剤微粒子
US10265265B2 (en)	2007-03-15	2019-04-23	Drug Delivery Solutions Limited	Topical composition
EP2008651A1 (en)	2007-06-26	2008-12-31	Drug Delivery Solutions Limited	A bioerodible patch
HUP0900072A2 (hu)	2009-02-06	2010-09-28	Egis Gyogyszergyar Nyilvanosan	Transzdermális gyógyszerkészítmények
US20090175810A1 (en)	2008-01-03	2009-07-09	Gareth Winckle	Compositions and methods for treating diseases of the nail
CN102655869B (zh)	2009-08-14	2016-08-10	博格有限责任公司	用于治疗脱发的维生素d3及其类似物
US8039494B1 (en)	2010-07-08	2011-10-18	Dow Pharmaceutical Sciences, Inc.	Compositions and methods for treating diseases of the nail
CN103533962B (zh)	2011-03-14	2018-05-18	药品配送方案有限公司	一种眼用组合物
HK1222819A1 (zh) *	2013-05-29	2017-07-14	博格有限责任公司	使用维生素d预防或减轻化疗诱发的脱发
MY179756A (en)	2013-10-03	2020-11-12	Dow Pharmaceutical Sciences	Stabilized efinaconazole formulations
EP3071295A4 (en)	2013-11-22	2017-05-31	Dow Pharmaceutical Sciences, Inc.	Anti-infective methods, compositions, and devices
JP6632006B2 (ja) *	2015-12-18	2020-01-15	ディーエスエムアイピーアセッツビー．ブイ．ＤｓｍＩｐＡｓｓｅｔｓＢ．Ｖ．	新規化合物
JP6972464B2 (ja) *	2015-12-18	2021-11-24	ディーエスエムアイピーアセッツビー.ブイ.Dsm Ip Assets B.V.	二芳香族ビタミンｄアナログ
KR20180095882A (ko) *	2015-12-18	2018-08-28	디에스엠 아이피 어셋츠 비.브이.	이중방향족 비타민 d 유사체
EP3389607B1 (en) *	2015-12-18	2020-07-15	DSM IP Assets B.V.	Biaromatic vitamin d analogs
EP3542788A1 (en)	2018-03-19	2019-09-25	MC2 Therapeutics Limited	Topical composition comprising calcipotriol and betamethasone dipropionate

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4678663A (en) *	1984-02-06	1987-07-07	Nuetrogena Corporation	Hydroquinone composition having enhanced bio-availability and percutaneous adsorption
US4525341A (en) *	1984-04-09	1985-06-25	Mayor Pharmaceutical Laboratories, Inc.	Method of administering vitamins
FI872553L (fi) *	1986-06-09	1987-12-10	American Cyanamid Co	Medium foer laekemedel foer lokalt bruk.
US4889845A (en) *	1986-06-09	1989-12-26	American Cyanamid Company	Vehicle for topical application of pharmaceuticals
JPH02145512A (ja) *	1988-11-26	1990-06-05	Shin Etsu Chem Co Ltd	被膜形成型外用剤
GB9109733D0 (en) *	1991-05-07	1991-06-26	Unilever Plc	Cosmetic composition
US6538039B2 (en)	1994-04-29	2003-03-25	Laboratoire L. Lafon	Pharmaceutical dosage form for transdermal administration
FR2719220A1 (fr) *	1994-04-29	1995-11-03	Lafon Labor	Nouvelle forme galénique pour l'administration transdermique.
FR2740038B1 (fr) *	1995-10-20	1998-01-02	Lafon Labor	Composition pour l'administration transdermique
FR2753626B1 (fr)	1996-09-20	1998-11-06	Centre International De Rech Dermatologiques Galderma Cird Galderma	Nouvelles compositions topiques sous forme d'emulsion fluide h/e a forte teneur en glycol pro-penetrant
FR2760971B1 (fr) *	1997-03-20	1999-12-10	Dow Corning Sa	Procede de production d'une composition a liberation controlee
GB9902812D0 (en) *	1998-06-18	1999-03-31	Dow Corning Sa	Composition for delivering pharmaceutically active agents
EP0966972B1 (en) *	1998-06-18	2003-09-24	Dow Corning France S.A.	Topical composition containing silicon gum
FR2785284B1 (fr) *	1998-11-02	2000-12-01	Galderma Res & Dev	Analogues de la vitamine d
FR2801305B1 (fr)	1999-11-24	2002-12-06	Galderma Res & Dev	Analogues de la vitamine d
FR2801307B1 (fr)	1999-11-24	2002-12-06	Galderma Res & Dev	Analogues de la vitamine d
FR2825087B1 (fr)	2001-05-22	2005-01-14	Galderma Res & Dev	Analogues de la vitamine d
FR2833258B1 (fr)	2001-12-10	2004-08-27	Galderma Res & Dev	Analogues de la vitamine d
US7655717B2 (en) *	2002-07-17	2010-02-02	Mary J. Goulbourne	Ointment composition for treating decubitus ulcers and methods for its making and its use
BRPI0406490A (pt) *	2003-02-05	2005-12-06	Galderma Res & Dev	Composições, composição cosmética ou dermatológica e uso de uma composição

2004
- 2004-11-17 JP JP2006540412A patent/JP2007511578A/ja active Pending
- 2004-11-17 ES ES04803732T patent/ES2302060T3/es not_active Expired - Lifetime
- 2004-11-17 PL PL04803732T patent/PL1686972T3/pl unknown
- 2004-11-17 EP EP08100323A patent/EP1952808A3/en not_active Withdrawn
- 2004-11-17 DE DE602004012440T patent/DE602004012440T2/de not_active Expired - Lifetime
- 2004-11-17 BR BRPI0416311-7A patent/BRPI0416311A/pt not_active IP Right Cessation
- 2004-11-17 EP EP04803732A patent/EP1686972B1/en not_active Expired - Lifetime
- 2004-11-17 MX MXPA06005587A patent/MXPA06005587A/es active IP Right Grant
- 2004-11-17 RU RU2006121973/15A patent/RU2006121973A/ru unknown
- 2004-11-17 DK DK04803732T patent/DK1686972T3/da active
- 2004-11-17 AT AT04803732T patent/ATE388697T1/de active
- 2004-11-17 WO PCT/EP2004/014085 patent/WO2005053666A1/en not_active Ceased
- 2004-11-17 PT PT04803732T patent/PT1686972E/pt unknown
- 2004-11-17 CA CA002543577A patent/CA2543577A1/en not_active Abandoned
- 2004-11-17 AU AU2004294728A patent/AU2004294728A1/en not_active Abandoned
2008
- 2008-05-13 CY CY20081100500T patent/CY1107942T1/el unknown

Also Published As

Publication number	Publication date
AU2004294728A1 (en)	2005-06-16
CY1107942T1 (el)	2013-09-04
BRPI0416311A (pt)	2006-12-26
EP1686972B1 (en)	2008-03-12
JP2007511578A (ja)	2007-05-10
DK1686972T3 (da)	2008-06-30
DE602004012440T2 (de)	2009-03-26
MXPA06005587A (es)	2006-08-11
WO2005053666A1 (en)	2005-06-16
EP1952808A2 (en)	2008-08-06
CA2543577A1 (en)	2005-06-16
EP1952808A3 (en)	2008-09-03
DE602004012440D1 (de)	2008-04-24
ATE388697T1 (de)	2008-03-15
ES2302060T3 (es)	2008-07-01
EP1686972A1 (en)	2006-08-09
PT1686972E (pt)	2008-04-23
RU2006121973A (ru)	2007-12-27

Publication	Publication Date	Title
PL1686972T3 (pl)	2008-09-30	Kompozycja możliwa do rozpylania dla podawania pochodnych witaminy D
MXPA05013232A (es)	2006-03-09	Composicion en forma de pulverizador que comprende un activo farmaceutico, al menos una silicona volatil y una fase aceitosa no volatil.
IL165022A0 (en)	2005-12-18	Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
WO2004066918A3 (en)	2005-04-28	Long wear cosmetic composition
EP1471955A4 (en)	2010-11-03	AEROSOL GENERATOR FOR A MEDICINAL FORMULATION
AU2003248703A1 (en)	2003-12-31	Stabilized retinol for cosmetic dermatological, and pharmaceutical compositions, and use thereof
EP1156770A4 (en)	2005-06-22	ANTIOXIDANT NATURAL COMPOSITIONS, PROCESS FOR THE PREPARATION AND COSMETIC, PHARMACEUTICAL AND NUTRITIONAL FORMULATIONS OF SAID COMPOSITIONS
AR046642A1 (es)	2005-12-14	Composicion en forma de spray que comprende un activo farmaceutico, al menos una silicona volatil y una fase aceitosa, no volatil
MX258711B (es)	2008-07-14	Derivados de merocianina para uso cosmetico.
MY156471A (en)	2016-02-26	Combination of lycopene, polyphenol and vitamins for the care of keratin material
BR0207731A (pt)	2004-03-23	Formulação cosmética compreendendo derivados de flavonóide
CY1107033T1 (el)	2012-09-26	Συνθεση στη μορφη σπρεϊ η οποια περιλαμβανει ενα συνδυασμο προπιονικης κλομπεταζολης και καλσιτριολης, μια αλκοολικη φαση και μια ελαιωδη φαση
DK1474491T3 (da)	2006-05-29	Anvendelse af antiadhæsive emballagematerialer til emballering af kemikalier og levnedsmidler
IL172423A0 (en)	2006-04-10	Novel formulations for opioid -based treatments of pain comprising substituted 1,4-di-piperidin-4-yl-piperazine derivatives
WO2003050067A3 (fr)	2004-03-04	Analogues de la vitamine d
MX260260B (es)	2008-09-04	Formulaciones semi-solidas para la administracion oral de taxoides.
TW200513264A (en)	2005-04-16	Remedy and a therapeutic method for periodontal diseases and pulpal diseases
SI1771180T2 (sl)	2011-02-28	Zmes v obliki prĹˇila, ki vsebuje kombinacijo klobetazol propionata in kalcitrola, alkoholna faza in oljna faza
HUP0204258A3 (en)	2005-03-29	Use of vitamin d-derivatives for preparation of pharmaceutical compositions useful in the treatment of osteoporosis and related bone disorders, as well as novel vitamin d3-derivatives
ITRM20020119A1 (it)	2003-09-05	Composizioni contenenti plgf ad uso farmaceutico e cosmetico.
AU2003258827A1 (en)	2004-01-19	Lactone compounds, for use as antioxidant agents in pharmaceutical, cosmetic or food compositions
IT1317818B1 (it)	2003-07-15	Procedimento per la produzione di componenti per integratorialimentari, formulazioni dietetiche, cosmetiche e farmaceutiche,
WO2004056326A3 (en)	2004-09-10	Bi-starch based compositions for topical use
SE0300830D0 (sv)	2003-03-26	New formulations and use thereof
AU2002364684A1 (en)	2003-07-15	Amphiphilic compounds for pharmaceutical or cosmetic use